FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for ...

Finasteride (Proscar) is more likely to cause problems with sexual function, but it is still uncommon. During the first year of treatment, erectile dysfunction was noted in 8.1% of finasteride-treated ...

Most men have about a 90% improvement in prostate symptoms immediately after the procedure, which was then reduced to about 50% improvement over their baseline after five years. UroLift is very ...

B.M.R. I am concerned that your understanding of the benefits of the UroLift procedure might be overly optimistic. UroLift ...

DEAR DR. ROACH: I’m 79, and for several years, I have been taking finasteride and tamsulosin for benign prostatic hyperplasia. (In the past, I underwent a TURP procedure, which I will never go through ...

I’m 79, and for several years, I have been taking finasteride and tamsulosin for benign prostatic hyperplasia. (In the past, I underwent a TURP procedure, which I will never go through again.) As we ...

As the prostate gland enlarges in men, which often happens in men above 50 years, urinary symptoms creep into men's most ...